USE OF IBRUTINIB FOR FLT3-ITD MUTATIONAL ACUTE LEUKEMIA

摘要

Disclosed is a new use of ibrutinib (PCI32765). It is particularly found that ibrutinib can be used for treating acute myeloid leukemia, especially acute myeloid leukemia carrying an FLT3/ITD mutant gene.